W Vos

Immunohistochemical profiling based on Bcl‐2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

JJF Muris, CJLM Meijer, W Vos et al. · The Journal of Pathology · 2006 · 233 citations

Life Sciences, Cell Biology, Oncology +17

Analysis of major histocompatibility complex class I expression on Reed- Sternberg cells in relation to the cytotoxic T-cell response in Epstein- Barr virus-positive and -negative Hodgkin's disease

JJ Oudejans, NM Jiwa, JA Kummer et al. · Blood · 1996 · 150 citations

Life Sciences, Immunology, Pathology +14

Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas

Jettie J.F. Muris, C J Meijer, Saskia A.G.M. Cillessen et al. · Leukemia · 2003 · 97 citations

Medicine, Oncology, Pathology +10

Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.

J J Oudejans, Mehdi Jiwa, A J van den Brule et al. · PubMed · 1995 · 94 citations

Life Sciences, Immunology, Pathology +8

Tissue distribution of the human CD97 EGF‐TM7 receptor

Lies H. Jaspars, W Vos, Gabriela Aust et al. · Tissue Antigens · 2001 · 90 citations · Full text

Life Sciences, Cell Biology, Pathology +12